Innergex Renewable Energy (INE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 production was 91% of long-term average, impacted by below-average wind, lower irradiance, and curtailments, but offset by strong hydro in Quebec and Chile and higher wind in the U.S. and Chile.
Adjusted EBITDA proportionate was $184M, down 8% year-over-year, with Free Cash Flow per Share up 181% to $0.26.
Major milestones included commissioning the 35 MW/175 MWh San Andrés BESS in Chile, advancing Boswell and Hale Kuawehi projects, and signing 30-year, CPI-indexed PPAs for 400 MW in Quebec.
Portfolio diversification by geography and technology, and disciplined growth strategy, are key to mitigating resource risk.
Texas portfolio de-risked by removing the last power hedge and selling minority interests, supporting deleveraging.
Financial highlights
Q2 2024 consolidated revenues and PTCs were $260M, down 4% year-over-year; net earnings were $23M, compared to $25M in Q2 2023.
Adjusted EBITDA proportionate was $184M, down 8% year-over-year; Free Cash Flow per Share was $0.26, up from $0.09 in Q2 2023.
Payout ratio for the trailing twelve months was 40%, down from 127% a year ago.
Total debt at quarter-end was ~$6.4B, down from Q1 2024, mainly due to Texas asset de-leveraging.
Net earnings margin for Q2 2024 was 8.8%.
Outlook and guidance
2024 Adjusted EBITDA proportionate guidance reaffirmed at $725M–$775M; Free Cash Flow per Share guidance at $0.70–$0.85.
CapEx budget for 2024 is fully funded; no material changes to full-year CapEx outlook.
Growth strategy focuses on responsible expansion, energy storage expertise, and asset diversification.
Expect more growth in 2025 as new projects come online.
Latest events from Innergex Renewable Energy
- 38% Texas asset stake sold for US$188M, removing final power hedge and reducing leverage.INE
Status Update3 Feb 2026 - Q3 2024 Adjusted EBITDA fell 3%, but Free Cash Flow and guidance remain strong.INE
Q3 202415 Jan 2026 - 2024 results exceeded guidance, with strong growth, new awards, and higher 2025 targets set.INE
Q4 202416 Dec 2025 - Revenue up 12% and net loss narrowed as CDPQ acquisition advances toward Q4 close.INE
Q1 20256 Jun 2025